Hoang Gia Nguyen

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam

Cam Phuong Pham, L. H. Trinh, Minh Hai Nguyen, 2024, BMC cancer.

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam

Cam Phuong Pham, L. H. Trinh, Minh Hai Nguyen, 2024, Therapeutic advances in medical oncology.